Literature DB >> 29517953

Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update Summary.

Randy A Taplitz1, Erin B Kennedy1, Christopher R Flowers1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29517953     DOI： 10.1200/JOP.18.00016

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  6 in total

1.  Clinical Implications of Febrile Neutropenia Guidelines in the Cancer Patient Population.

Authors:  Catherine C Braga; Randy A Taplitz; Christopher R Flowers
Journal:  J Oncol Pract       Date:  2019-01       Impact factor: 3.840

2.  Survey of serious adverse events and safety evaluation of oral anticancer drug treatment in Japan: A retrospective study.

Authors:  Kenji Kawasumi; Azusa Kujirai; Reiko Matsui; Yohei Kawano; Masakazu Yamaguchi; Takao Aoyama
Journal:  Mol Clin Oncol       Date:  2020-11-25

Review 3.  [Systematic action-Emergencies in systemic cancer therapy!]

Authors:  Martin Bögemann
Journal:  Urologie       Date:  2022-05-24

4.  Potential reduction of hospital stay length with outpatient management of low-risk febrile neutropenia in a regional cancer center.

Authors:  Mike Nguyen; Tate Jacobson; Javier Torres; Alysson Wann
Journal:  Cancer Rep (Hoboken)       Date:  2021-02-26

5.  Remote Monitoring of Patients With Hematologic Malignancies at High Risk of Febrile Neutropenia: Exploratory Study.

Authors:  Arash Naeim; Maxwell Kroloff; Ramin Ramezani; Holly Wilhalme
Journal:  JMIR Form Res       Date:  2022-01-25

6.  Blood culture utilization practices among febrile and/or hypothermic inpatients.

Authors:  Kap Sum Foong; Satish Munigala; Stephanie Kern-Allely; David K Warren
Journal:  BMC Infect Dis       Date:  2022-10-10       Impact factor: 3.667
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.